SecBot SecBot

MEOH

METHANEX CORP
Nasdaq· Industrial Organic Chemicals· Inc. A1· CIK 0000886977 Biotech & Drug Discovery
$66.89 −3.62 (−5.13%)
Nov 16 4:00 PM ET · prev $70.51
Market cap
$5.4B
Mid cap
Consensus
Buy
79% Buy or better · 14 analysts
Median target
$81.00
+21% · range $63.00–87.00
1 year
+87.3%
from $35.71 · Nov 17
30 days
+3.7%
from $64.49
52-week range
$34.03–71.57
−7% from high · low Nov 20
Avg volume 20D
866.3K
Oct 30 spike 2.77M
Short interest
2.41M
≈3.1% of shares · +1.8%
Days to cover
3.4
at average volume
New fund stakes
1
Q2 2026 13F · 3 exits
Filing reports
18
analyzed by SecBot
SecBot read BULLISH 13 reports · 90 days
Balance 1 bearish · 3 bullish · 1 mixed · 8 neutral oldest → newest, height = score
Avg score ·High conf. 9/13

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InstitutionsMIXED

    Q2 2026: 30 added (1 new), 22 trimmed or exited. Largest new: Qube Research & Technologies $18.6M.

  • AnalystsBULLISH

    11 of 14 rate it Buy or better. Median target $81.00 (+21%).

  • Short sellersSTEADY

    Short interest +1.8% to 2.41M shares. 3.4 days to cover, ≈3.1% of shares.

  • TrendUPTREND

    6% above its 50-day average.

  • SocialQUIET

    No Reddit mentions this week. Last mention Oct 30.

Who's buying

13F· Q2 2026
1
new positions
3
exits
$18.6M
in new stakes
FundMoveSharesValue
Boston PartnersADD4,168,956$192.8M
FIL LtdTRIM1,914,152$88.4M
MILLENNIUM MANAGEMENT LLCDOUBLED1,559,557$72.0M
ROYAL BANK OF CANADAADD1,308,931$60.4M
BANK OF AMERICA CORP /DE/ADD1,228,227$56.7M
Connor, Clark & Lunn Investment Management Ltd.TRIM1,161,686$53.6M
Point72 Asset Management, L.P.DOUBLED929,018$42.9M
D. E. Shaw & Co., Inc.DOUBLED903,581$41.7M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

14 analysts
Buy 79% rate it Buy or better
Strong Buy4Buy7Hold3Sell0Strong Sell0
12-month targets · 10 analysts

Price is inside the target range. Median implies +21%.Targets as of Nov 16, 2026.

Recent actions
DateFirmActionRating
Nov 2, 2026CIBC
MAINTAIN
MAINTAINOutperformer
Nov 2, 2026RBC Capital
MAINTAIN
MAINTAINSector Perform
Nov 2, 2026JP Morgan
MAINTAIN
MAINTAINNeutral
Oct 5, 2026UBS
MAINTAIN
MAINTAINBuy
Jul 31, 2026UBS
MAINTAIN
MAINTAINBuy
Jul 20, 2026CIBC
UPGRADE
UPGRADEOutperformer

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY$11.84$10.80–$12.66+29.9%$5.2B
Next FY🔒 Fresh data, subscribers only
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

Short side

FINRA· Oct 30, 2026
2,405,731
shares short
+1.8%
vs prior settlement
3.4
days to cover
≈3.1%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 16, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Nov 16, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Nov 13, 2026 SEC
Boston Partners filed an amended Schedule 13G, reporting beneficial ownership of 4,696,568.7 common shares of Methanex…
SC 13G/A · Impact 2/10
Oct 29, 2026 Earnings
Methanex Reports Higher Earnings and Cash Flows in Third Quarter 2026
Except where otherwise noted, all currency amounts are stated in United States dollars.
Oct 29, 2026 Press
Methanex announced a Normal Course Issuer Bid to repurchase up to 3,868,213 common shares (5% of outstanding) over the…
Impact 3/10
Jun 30, 2026 Inst.
Boston Partners · ADD
4,168,956 shares ($192.8M)
Jun 30, 2026 Inst.
FIL Ltd · TRIM
1,914,152 shares ($88.4M)
Apr 29, 2026 Press
Methanex declared a quarterly dividend of $0.185 per share, payable June 30, 2026, to shareholders of record on June…
Impact 2/10

Washington

Corporate Lobbying

5 lobbying filings and 0 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

SecBot reports

18 filings · 3 press releases · 3 bullish · 4 bearish · 2 mixed · 9 neutral
All MEOH filing & press-release reports (21)